| Name | Title | Contact Details |
|---|
Canadian Health and Lifestyle Magazine is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Unistrut Corporation a division of Tyco is a Wayne, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
You have many choices when it comes to taking care of the precious gift of your health and that of your loved ones. For over ninety years, Baptist Health System has been taking care of our communities. The reason to choose Baptist today? It comes down to nationally recognized, high-quality care driven by our purpose, to Honor God and Others. It`s the Baptist network of doctors and healthcare professionals that can now work together to coordinate your care because of innovative technology such as electronic medical records. It`s the focus on whole person healing, prevention and the experience of patients and families trusting us with their care.
CC Ford Group is a Bernardsville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.